TCS 21311

Names

[ Name ]:
TCS 21311

[Synonym ]:
NIBR-3049

Biological Activity

[Description]:

TCS 21311 (NIBR3049) is a potent, highly selective JAK3 inhibitor with an IC50 of 8 nM, it displays >100-fold selectivity over JAK1, JAK2 and TYK2. TCS 21311 (NIBR3049) inhibits PKCα, PKCθ, and GSK3β with IC50s of 13, 68, and 3 nM, respectively[1].

[Related Catalog]:

Signaling Pathways >> Epigenetics >> PKC

Signaling Pathways >> Stem Cell/Wnt >> GSK-3

Signaling Pathways >> JAK/STAT Signaling >> JAK

Signaling Pathways >> Epigenetics >> JAK

Signaling Pathways >> Stem Cell/Wnt >> JAK

Research Areas >> Others

Signaling Pathways >> TGF-beta/Smad >> PKC

Signaling Pathways >> PI3K/Akt/mTOR >> GSK-3

[Target]

JAK3:8 nM (IC50)

JAK2:2.55 μM (IC50)

JAK1:1.017 μM (IC50)

PKCα:13 nM (IC50)

PKCθ:68 nM (IC50)

GSK-3β:3 nM (IC50)

[In Vitro]

TCS 21311 (NIBR3049) exhibits IC50 values of 1.017, 2.550 and 8.055 μM for JAK1, JAK2 and TYK2, respectively in a enzymatic Jak assay[1]. TCS 21311 (NIBR3049) shows moderate activity in this cellular assay (IC50=689 nM, Jurkat cells), which is in good agreement with its enzymatic Pkc activity[1].

[References]

[1]. Thoma G, et al. Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family.J Med Chem. 2011 Jan 13;54(1):284-8.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₇H₂₅F₃N₄O₄

[ Molecular Weight ]:
526.50700

[ Exact Mass ]:
526.18300

[ PSA ]:
109.23000

[ LogP ]:
3.45220

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.